Comparison of Characteristics and Survival between Prospective and Retrospective Korea Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Cohort Studies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jun Hyoung | - |
dc.contributor.author | Choi, Yunsu | - |
dc.contributor.author | Song, Joon Young | - |
dc.contributor.author | Kim, Shin-Woo | - |
dc.contributor.author | Kim, Sang Il | - |
dc.contributor.author | Kee, Mee-Kyung | - |
dc.contributor.author | Choi, Bo Youl | - |
dc.contributor.author | Choi, Jun Yong | - |
dc.date.accessioned | 2022-07-08T20:27:42Z | - |
dc.date.available | 2022-07-08T20:27:42Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/146668 | - |
dc.description.abstract | By comparing the data of prospectively and retrospectively enrolled cohorts, we evaluated whether the prospective cohort represented all patients in the retrospective cohort. The prospectively enrolled subjects were older and had lower CD4+ T cell counts, higher viral load. In addition, the initial antiretroviral treatment regimen of the prospective cohort consisted of less integrase strand transfer inhibitor-containing regimens. The 20-year survival rate was 51.8% in the prospective cohort and 84.6% in the retrospective cohort, respectively (P = 0.844). This study suggests the prospective cohort study may not represent all patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CHEMOTHERAPY | - |
dc.title | Comparison of Characteristics and Survival between Prospective and Retrospective Korea Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Cohort Studies | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Bo Youl | - |
dc.identifier.doi | 10.3947/ic.2019.51.4.393 | - |
dc.identifier.scopusid | 2-s2.0-85078169022 | - |
dc.identifier.wosid | 000505078200007 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.51, no.4, pp.393 - 398 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 51 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 393 | - |
dc.citation.endPage | 398 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002546124 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | HIV-INFECTED PATIENTS | - |
dc.subject.keywordPlus | SELECTION BIAS | - |
dc.subject.keywordAuthor | HIV/AIDS | - |
dc.subject.keywordAuthor | Cohort study | - |
dc.subject.keywordAuthor | Survival rates | - |
dc.identifier.url | https://icjournal.org/DOIx.php?id=10.3947/ic.2019.51.4.393 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.